• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

    Reed-Lane Facility Virtual Tour
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Almac Group

    Cytovance Biologics

    Adare Pharma Solutions

    Alcami

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Almac Group

    Adare Pharma Solutions

    Reed-Lane

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Taking Aim Against Pharmaceutical Counterfeiting

    Pharmaceutical serialization is soon to be a reality, leaving manufacturers and suppliers to find and implement the best solutions.

    Related CONTENT
    • Tackling TB Resistance
    • Innovative Manufacturing Technology for Aseptic Filling
    • ANI Launches Indapamide Tablets
    • Newsmakers: Peter Soelkner
    • Mayne Pharma Acquires Pars’ Generic Pain Patch
    Daniela Guttmann , Vetter Pharma International GmbH09.08.14
    According to the World Health Organization (WHO), counterfeit drugs are a major risk for patients, resulting in treatment failures, and in some cases, death. They also inflict enormous economic damage. It is estimated that up to 10% of all drugs sold worldwide are counterfeit. In some countries the share is as much as 50 percent. According to the WHO, counterfeit drugs have an estimated market value of approximately $75 billion dollars1 a year within an overall pharma market of $965 billion2.

    Drug counterfeiters are increasingly focused on critically needed pharmaceuticals such as antibiotics or cancer treatment. Regulatory authorities and businesses alike want to counter this trend by making medicines traceable from manufacturing and distribution, on through to the pharmacy. The manner in which this can be accomplished is through serialization, which is a process by which the smallest unit of packaging is given a unique identification number.

    Until recently, the investment in equipment and know-how for the serialization of drugs was a difficult hurdle for drug manufactures. This was partly attributable to a long-standing uncertainty in the U.S. market and the lack of uniform rules within the U.S. Thus, states like California did not proceed with their own regulations until late last year when Congress adopted the Drug Quality and Safety Act (DQSA) with corresponding requirements for the entire country.

    Since then, this issue has been gaining importance among manufacturers and suppliers of drug products. Other countries as well have been focused on the issue of serialization. In many, regulations are already in place, or soon to be introduced in the next few years.

    What Challenges Does the Industry Face?
    Even if the legislators and authorities of various countries are united towards one goal, their approaches differ. All agree that they want to achieve unique identification and clear verification of the authenticity of products. However, when it comes to monitoring there are two fundamental approaches in the regulations that are followed:
    • A point of dispense authentication
    • Continuous track and trace solution
    In the European Union, the point of dispense authentication is preferred. With this system, when dispensing a drug to the patient, the product can be determined to be exactly what the label says it is. By 2017 manufacturers will be required to print a unique, machine-readable 2D code on all sales packaging. In addition, all cartons must have a tamper evident seal. Before delivery, the codes have to be sent to a central regulatory agency database for recording. When dispensing to the patient, the pharmacist compares the code on the packaging with that in the database. Once dispensed, the status in the database is changed to reflect the status of “dispensed”. Other countries want to go further than that, expecting that in addition to clear verification, one is able to check the products throughout the entire supply chain.

    The U.S. is striving to implement an electronic system for track-and-trace of all drugs within the next ten years. The precondition is that manufacturers must implement serialization by the end of 2017. In addition, some countries, such as, Turkey, India and Argentina, have required serialization for drugs for some time. China is currently under implementation. Drug companies that sell their products in more than one market are now facing challenges dealing with the different regulations.

    Up Against Varying Requirements
    As in other areas, requirements for serialization differ between individual countries, in some cases substantially. Thus, different countries have different requirements relating to:
    • Serialization data
    • Serial number characteristics
    • Tracking requirements
    • Reporting requirements
    If manufacturers supply several markets, they need flexible serialization solutions in order to respond to these variations and must also provide different formats for serial numbers and codes. They should also be able to offer point of dispense authentication as well as a subsequent integration into a consistent track-and-trace system. Therefore, companies have to establish “parent-child” relationships between the sales unit to shipping case, and shipping case to transport pallet.

    Provide Modular Solutions
    What then must a serialization solution take into account and provide for? Although there are different approaches and methods, for all systems the following elements are the same:
    • Options and formats for different serial numbers
    • A defined area for serial numbers on packaging
    • IT solutions for the management of serialization data through to aggregation and batch sampling
    • Technical systems for requesting, printing, reading and verifying data serialization
    • Interfaces for data transfer
    • Processes for quality control and assurance
    For compliance with regulatory requirements, manufacturers should identify sales packaging with unique serial numbers and identification labeling. This information must be readable for both humans and machines. The basis for this may be 1-D linear codes or 2-D data matrix codes. The labeling follows the GS1 structure and includes GTIN, unique serial number, batch number and expiry date. Each sales unit is first aggregated with the shipping case according to the ‘parent-child’ principle. A 2-D data matrix code provides in addition to the information above, the number of boxes enclosed. Additionally, the pallets can be clearly identified with a 1-D linear barcode and the shipping case aggregated with the pallets according to the”parent-child” principle. For this, a SSCC-18 (Serial Shipping Container Code) is used. Depending on needs, the generation of serial numbers can either follow in a sequential or random order. Moreover, the security codes can be expanded to include additional identification information.

    Enabling Data Exchange
    Essential components for the successful implementation of a serialization solution involve both an IT software and a technical implementation on the packaging lines. For example, with corresponding IT capabilities on the packaging lines, printing as well as management and exchange of serial numbers are necessary. Integration into the existing IT landscape is absolutely crucial. Thus the solution must be linkable to systems for enterprise application integration and must be able to communicate with them accordingly. A connection to ERP systems is necessary to start orders and to report back with the printing information. Object events need to be recorded for the required reports and documentation. Finally, the production must be controlled locally via an on-site server. Useful applications for process integration as provided by SAP PI are at the heart of such a solution. Thus, in addition to common interfaces (EPCIS), transfer protocols (AS2) and messages based on XML with EPCIS design, other solutions are possible. The dialog across various systems provides a number of options for documentation such as commissioning reports for serial numbers after packaging, decommissioning reports, serialized advanced shipping notifications (sASN), as well as documentation required for future use.  Samples can be implemented in production by default via in-process controls. Linking up with mobile solutions could also allow batch sampling with the appropriate identification labeling to be done in the warehouse.

    Clear Benefits for Everyone
    In best practice, serialization provides the smallest unit of packaging with a singular labeling via a unique identification number, creating the basis for increased safety and efficiency along the supply chain. Companies can use the system to identify potential for process optimization. With a track-and-trace program, internal and external distribution channels are comprehensive and transparent, which will not only save money but also make counterfeiting more difficult, and support medical personnel and patients alike. One can be sure that the drug you are using is actually the real product. Finally, drug manufacturers also benefit from serialization because counterfeits are more easily recognizable; considerably reducing not just the economic loss but also the damage that might be done to the corporate image. 


    Daniela Guttmann is, Product and Service Manager, Vetter Pharma International GmbH. She has an MBA in International Business Development from the ESB Business School Reutlingen, Germany. She started her career path in the pharmaceutical industry in 2003 contributing to different areas of the business in Latin America and Europe. Daniela joined Vetter in 2011, where she is a product and service manager responsible for secondary packaging, serialization and sterile water for injection services.

    References
    1. WHO http://www.who.int/bulletin/volumes/88/4/10-020410/en/ 
    2. IMS Health http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/vgnextoid=96bdd595ae072410VgnVCM10000076192ca2RCRD&vgnextfmt=default 
    Related Searches
    • Development
    • Pharma
    • Manufacturing
    • Sterile
    Suggested For You
    Tackling TB Resistance Tackling TB Resistance
    Innovative Manufacturing Technology for Aseptic Filling Innovative Manufacturing Technology for Aseptic Filling
     ANI Launches Indapamide Tablets ANI Launches Indapamide Tablets
    Newsmakers: Peter Soelkner Newsmakers: Peter Soelkner
    Mayne Pharma Acquires Pars’ Generic Pain Patch  Mayne Pharma Acquires Pars’ Generic Pain Patch
    Apotex Spends $184mn to Grow U.S. Mfg. Presence Apotex Spends $184mn to Grow U.S. Mfg. Presence
    Mayne Pharma Enters License/Supply Pact Mayne Pharma Enters License/Supply Pact
    Vetter Vetter's Ravensburg Ops Underway
    ANI Launches Lithobid Generic ANI Launches Lithobid Generic
    Vetter Pharma International Vetter Pharma International
    Vetter Data Processing Center Gains Certification Vetter Data Processing Center Gains Certification
    Developing a Lyophilized Drug Product? Don’t Forget the Diluent Developing a Lyophilized Drug Product? Don’t Forget the Diluent
    Trials and Tribulations of Vaccinations Trials and Tribulations of Vaccinations
    Vaccine Outsourcing Vaccine Outsourcing
    Vetter Dedicates New U.S. Facility Vetter Dedicates New U.S. Facility

    Related Features

    • Solid Dosage/Semi-solids
      Hygienic Packaging Technology

      Hygienic Packaging Technology

      Growing consumer demand for health products highlights hygienic packaging.
      John Brown, Vice President of Global Marketing, Selig 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Trends in Solid Oral Dosage Delivery

      Trends in Solid Oral Dosage Delivery

      Capsule demand continues to rise due to this delivery system’s versatility.
      Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules 03.01.21

    • Information Technology
      5 Reasons Paper Has No Place in Contract Manufacturing

      5 Reasons Paper Has No Place in Contract Manufacturing

      Digital solutions create more efficient manufacturing processes and eliminate delays.
      Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21


    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Pharmaceutical Manufacturing  Equipment Trends

      Pharmaceutical Manufacturing Equipment Trends

      Demand for flexibility remains the driving force behind equipment systems.
      Kristin Brooks, Managing Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Nutraceutical Manufacturing:  Meeting the Challenges of Today, Planning for  Tomorrow

      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Companies continue balancing high demand, supply disruption, and worker safety during the pandemic.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • 2021 Contract  Manufacturing Survey

      2021 Contract Manufacturing Survey

      Our fourth annual audience poll indicates continued reliance on manufacturing partners, particularly for small businesses.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • APIs
      Small Molecule Development Trends

      Small Molecule Development Trends

      A Q&A with Cambrex Edinburgh’s site director, Mark Benger.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • APIs | Cytotoxics and High Potency Manufacturing
      Challenges & Opportunities Facing Small & Emerging Biopharma Companies

      Challenges & Opportunities Facing Small & Emerging Biopharma Companies

      A Q&A with Christian Dowdeswell, vice president and head of commercial development for small molecules at Lonza.
      Tim Wright, Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Development and manufacture of medicated chewing gum continues to gain momentum.
      Rukayat Adedeji, Contributing Writer 03.01.21

    • APIs
      Small Molecule API CDMO: A Capital Intensive Business?

      Small Molecule API CDMO: A Capital Intensive Business?

      Exploring small molecule API market trends.
      Dr. Michele Jermini and Dr. Enrico Polastro, Contributing Writers 03.01.21


    • Serialization
      Serialization: Level 5 Solution

      Serialization: Level 5 Solution

      Why a Level 5 solution is required for small pharma companies to fully harness serialization investment.
      Steve Wood, President & CEO, Covectra 03.01.21

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    Trending
    • Catalent Acquires Delphi Genetics
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • Matica Biotechnology Breaks Ground On Cell And Gene Therapy Site
    • Celonic Group Announces Plans For New Facility In Switzerland
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    • Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    • Aptamer Extends Collaboration with AstraZeneca
    • Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President and COO
    Ashland Completes Expansion and Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Global Hair Color Market Forecasted to Grow
    Happi

    Latest Breaking News From Happi

    Dr. Sheffield’s Adds New Toothpaste Flavors
    First Two Hand Sanitizers Are Certified by Green Seal
    Elizabeth Arden Taps Supermodel and Actress Sui He
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Full-Year Sales Down 12 Percent at Zimmer Biomet
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login